Changeflow GovPing Healthcare & Life Sciences Nucleic Acid Purification Using Mixed Mode Resins
Routine Notice Added Final

Nucleic Acid Purification Using Mixed Mode Resins

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

USPTO published patent application US20260109965A1 titled 'Purification of Nucleotides by Means of a Mixed-Mode Purification System,' filed September 27, 2023 (Application No. 19115842). The invention relates to purification of nucleotides using mixed mode resins and names four inventors: Jennifer Beaudoin, Matthew J. Burak, Christopher Ladd Effio, and Haripriya Sharma. CPC classifications include C12N 15/101, B01J 20/262, and C12N 15/1017.

“This disclosure relates to purification of nucleotides using mixed mode resins.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 236 changes logged to date.

What changed

USPTO published patent application US20260109965A1 for a mixed-mode purification system used in nucleotide purification. The application was filed on September 27, 2023, under Application No. 19115842, and names Jennifer Beaudoin, Matthew J. Burak, Christopher Ladd Effio, and Haripriya Sharma as inventors. The published application is classified under CPC categories C12N 15/101, B01J 20/262, and C12N 15/1017.

Affected parties in biotechnology, pharmaceutical, and life sciences sectors involved in nucleic acid or nucleotide purification technologies should review this published application to assess potential patent landscape implications. Competitors developing similar mixed-mode resin purification methods may need to evaluate freedom-to-operate considerations.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

PURIFICATION OF NUCLEOTIDES BY MEANS OF A MIXED-MODE PURIFICATION SYSTEM

Application US20260109965A1 Kind: A1 Apr 23, 2026

Inventors

Jennifer Beaudoin, Matthew J. Burak, Christopher Ladd Effio, Haripriya Sharma

Abstract

This disclosure relates to purification of nucleotides using mixed mode resins.

CPC Classifications

C12N 15/101 B01J 20/262 C12N 15/1017

Filing Date

2023-09-27

Application No.

19115842

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260109965A1

Who this affects

Applies to
Pharmaceutical companies Manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Patent filing IP protection
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Biotechnology

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!